levamisole has been researched along with daunorubicin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Haskell, CM | 1 |
| Athens, JW; Balcerzak, SP; Coltman, CA; Costanzi, JJ; Dabich, L; Gumbart, C; Head, DR; Kopecky, KJ; Morrison, FS; Saiki, JH | 1 |
| Filatov, PP; Vatin, AE | 1 |
| Birman, V; Braier, JL; Bustelo, P; Dibar, E; Divito, J; Eppinger-Helft, M; Failace, R; Garay, G; Kvicala, R; Pavlovsky, S; Peñalver, J; Sackmann Muriel, F; Svarch, E; Vergara, B | 1 |
1 review(s) available for levamisole and daunorubicin
| Article | Year |
|---|---|
Immunologic aspects of cancer chemotherapy.
Topics: Animals; BCG Vaccine; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Fluorouracil; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Immunotherapy; Levamisole; Mercaptopurine; Methotrexate; Mice; Neoplasms; Propionibacterium acnes; Vinca Alkaloids | 1977 |
1 trial(s) available for levamisole and daunorubicin
| Article | Year |
|---|---|
Late intensification with POMP chemotherapy prolongs survival in acute myelogenous leukemia--results of a Southwest Oncology Group study of rubidazone versus adriamycin for remission induction, prophylactic intrathecal therapy, late intensification, and l
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Combined Modality Therapy; Daunorubicin; Doxorubicin; Humans; Immunotherapy; Leukemia, Myeloid, Acute; Levamisole; Mercaptopurine; Methotrexate; Nervous System Neoplasms; Prednisone; Survival Analysis; Vincristine | 1992 |
5 other study(ies) available for levamisole and daunorubicin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
[Antitumor activity and the effect on immunogenesis of combinations of rubomycin and carminomycin with levamisole].
Topics: Animals; Antibody Formation; Carubicin; Daunorubicin; Dose-Response Relationship, Immunologic; Drug Combinations; Drug Evaluation, Preclinical; Drug Hypersensitivity; Hypersensitivity, Delayed; Immunity, Cellular; Levamisole; Lymphoma, Non-Hodgkin; Male; Mice; Mice, Inbred Strains; Neoplasms, Experimental | 1982 |
[Treatment of acute lymphoblastic leukemia. Results with 1,192 patients].
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Daunorubicin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leukemia, Lymphoid; Levamisole; Methotrexate; Prednisone; Vincristine | 1981 |